Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Rodríguez-Baño et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2020.08.010
https://c19early.org/rodriguezbano.html